Currently, there are 683.03M common shares owned by the public and among those 681.09M shares have been available to trade.
The company’s stock has a 5-day price change of -5.70% and 21.61% over the past three months. CTVA shares are trading 37.92% year to date (YTD), with the 12-month market performance up to 26.56% higher. It has a 12-month low price of $50.30 and touched a high of $77.41 over the same period. CTVA has an average intraday trading volume of 3.83 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.40%, 1.24%, and 14.35% respectively.
Institutional ownership of Corteva Inc (NYSE: CTVA) shares accounts for 86.73% of the company’s 683.03M shares outstanding.
It has a market capitalization of $49.18B and a beta (3y monthly) value of 0.75. The stock’s trailing 12-month PE ratio is 43.95, while the earnings-per-share (ttm) stands at $1.64. The company has a PEG of 2.69 and a Quick Ratio of 1.00 with the debt-to-equity ratio at 0.17. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.90% over the week and 1.67% over the month.
Analysts forecast that Corteva Inc (CTVA) will achieve an EPS of 1.86 for the current quarter, -0.37 for the next quarter and 3.54 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.7 while analysts give the company a high EPS estimate of 1.7. Comparatively, EPS for the current quarter was 1.83 a year ago. Earnings per share for the fiscal year are expected to increase by 17.58%, and 17.17% over the next financial year.
Looking at the support for the CTVA, a number of firms have released research notes about the stock. Argus stated their Buy rating for the stock in a research note on March 31, 2025, with the firm’s price target at $69. Goldman coverage for the Corteva Inc (CTVA) stock in a research note released on March 13, 2025 offered a Buy rating with a price target of $71. Citigroup was of a view on October 23, 2024 that the stock is Buy, while BofA Securities gave the stock Buy rating on October 16, 2024, issuing a price target of $59- $67. Argus on their part issued Hold rating on August 07, 2024.
